Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Net Income towards Common Stockholders (2017 - 2025)

Historic Net Income towards Common Stockholders for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $744865.0.

  • Selectis Health's Net Income towards Common Stockholders rose 14613.25% to $744865.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$818094.0, marking a year-over-year increase of 8515.41%. This contributed to the annual value of -$2.4 million for FY2024, which is 3885.35% up from last year.
  • As of Q3 2025, Selectis Health's Net Income towards Common Stockholders stood at $744865.0, which was up 14613.25% from -$315527.0 recorded in Q2 2025.
  • Over the past 5 years, Selectis Health's Net Income towards Common Stockholders peaked at $4.0 million during Q1 2023, and registered a low of -$3.6 million during Q4 2023.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$670969.0 (2025), whereas its average is -$574345.5.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first tumbled by 155050.75% in 2022, then surged by 165690.64% in 2023.
  • Over the past 5 years, Selectis Health's Net Income towards Common Stockholders (Quarter) stood at -$1.8 million in 2021, then decreased by 23.87% to -$2.2 million in 2022, then tumbled by 65.5% to -$3.6 million in 2023, then skyrocketed by 84.17% to -$576463.0 in 2024, then surged by 229.21% to $744865.0 in 2025.
  • Its Net Income towards Common Stockholders stands at $744865.0 for Q3 2025, versus -$315527.0 for Q2 2025 and -$670969.0 for Q1 2025.